Skip to main content
Premium Trial:

Request an Annual Quote

Nucleonics Challenges Second Benitec RNAi Patent in Australia

NEW YORK, Nov. 2 (GenomeWeb News) - Nucleonics is challenging a second RNAi patent held by Benitec and the Commonwealth Scientific and Industrial Research Organization in Australia, the Horsham, Pa.-based company said today.


Nucleonics filed a request with the commissioner of patents in Australia that the patent, Australian Innovation Patent No. 2001100608, be re-examined. The company believes the patent, entitled "Control of Gene Expression," claims lack novelty or did not involve an innovative step at the time the patent application was filed.


This is Nucleonics's third challenge of an RNAi patent held by Benitec and CSIRO within two months.  In September, it challenged another patent in Australia in October it asked the USPTO to re-examine a US patent.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.